Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03912337
Recruitment Status : Terminated (Study would not complete enrollment target until 2026 with results available in 2027. The information will not be useful at that time.)
First Posted : April 11, 2019
Last Update Posted : November 19, 2021
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 26, 2021
Actual Study Completion Date : July 26, 2021